Evidence from studies in rodents and in isolated adipocytes that agonists of the chemerin receptor CMKLR1 may be beneficial in the treatment of type 2 diabetes

Contrasting effects of cold acclimation versus obesogenic diets on chemerin gene expression in brown and brite adipose tissues

(2014) Ida R. Hansen et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Chemokine-Like Receptor 1 Deficiency Does Not Affect the Development of Insulin Resistance and Nonalcoholic Fatty Liver Disease in Mice

(2014) Nanda Gruben et al.   PLoS One

ChemR23 knockout mice display mild obesity but no deficit in adipocyte differentiation

(2013) Laurie Rouger et al.   JOURNAL OF ENDOCRINOLOGY

Chemerin gene expression is regulated by food restriction and food restriction–refeeding in rat adipose tissue but not in liver

(2013) Ewa Stelmanska et al.   REGULATORY PEPTIDES

Pioglitazone and metformin are equally effective in reduction of chemerin in patients with type 2 diabetes

(2013) Alireza Esteghamati et al.   Journal of Diabetes Investigation

CHEMERIN IS AN INDEPENDENT MARKER OF THE METABOLIC SYNDROME IN A CAUCASIAN POPULATION - A PILOT STUDY

(2012) David Stejskal et al.   BIOMEDICAL PAPERS-OLOMOUC

Increased adipose tissue hypoxia and capacity for angiogenesis and inflammation in young diet-sensitive C57 mice compared with diet-resistant FVB mice

(2012) D-H Kim et al.   INTERNATIONAL JOURNAL OF OBESITY

Disruption of the Chemokine-Like Receptor-1 (CMKLR1) Gene Is Associated with Reduced Adiposity and Glucose Intolerance

(2011) Matthew C. Ernst et al.   ENDOCRINOLOGY

Chemerin, a Novel Peroxisome Proliferator-activated Receptor γ (PPARγ) Target Gene That Promotes Mesenchymal Stem Cell Adipogenesis

(2011) Shanmugam Muruganandan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Identification of chemerin receptor (ChemR23) in human endothelial cells: Chemerin-induced endothelial angiogenesis

(2010) Jaspreet Kaur et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Chemerin Exacerbates Glucose Intolerance in Mouse Models of Obesity and Diabetes

(2010) Matthew C. Ernst et al.   ENDOCRINOLOGY

Roles of GPR41 and GPR43 in leptin secretory responses of murine adipocytes to short chain fatty acids

(2010) Mohamed S. Zaibi et al.   FEBS LETTERS

Chemerin, a Novel Adipokine in the Regulation of Angiogenesis

(2010) Kiymet Bozaoglu et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Chemerin Peptides Promote Phagocytosis in a ChemR23- and Syk-Dependent Manner

(2010) J. L. Cash et al.   JOURNAL OF IMMUNOLOGY

Differential effects of sucrose and fructose on dietary obesity in four mouse strains

(2010) John I. Glendinning et al.   PHYSIOLOGY & BEHAVIOR

Chemerin: at the crossroads of inflammation and obesity

(2010) Matthew C. Ernst et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Chemerin Is a Novel Adipocyte-Derived Factor Inducing Insulin Resistance in Primary Human Skeletal Muscle Cells

(2009) Henrike Sell et al.   DIABETES

Chemerin Is Associated with Metabolic Syndrome Phenotypes in a Mexican-American Population

(2009) Kiymet Bozaoglu et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

C/EBP  and the Corepressors CtBP1 and CtBP2 Regulate Repression of Select Visceral White Adipose Genes during Induction of the Brown Phenotype in White Adipocytes by Peroxisome Proliferator-Activated Receptor   Agonists

(2009) C. Vernochet et al.   MOLECULAR AND CELLULAR BIOLOGY

Identification of a stable chemerin analog with potent activity toward ChemR23

(2009) Ken Shimamura et al.   PEPTIDES

Interleukin-1ß induces the novel adipokine chemerin in adipocytes in vitro

(2009) Susan Kralisch et al.   REGULATORY PEPTIDES

Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes

(2008) Michiko Takahashi et al.   FEBS LETTERS

Synthetic chemerin-derived peptides suppress inflammation through ChemR23

(2008) Jenna L. Cash et al.   JOURNAL OF EXPERIMENTAL MEDICINE